Latest News
Caris Life Sciences introduces Caris Detect multi-cancer early detection blood test
1 July 2026 - AI TechBio company Caris Life Sciences (NASDAQ: CAI) declared on Wednesday that it has launched Caris Detect, a multi-cancer early detection blood test designed to identify cancer signals at earlier and more treatable stages using ultra...
Cumberland Pharmaceuticals sharpens focus on rare disease pipeline with USD100m sale of branded US business to Apotex
1 July 2026 - US biopharmaceutical company Cumberland Pharmaceuticals Inc (Nasdaq: CPIX) announced on Wednesday that it has completed a USD100m transaction with Apotex, a subsidiary of Canadian-based pharmaceutical company Apotex Health Corp, under w...
Co-Diagnostics advances toward FDA filing after completing clinical validation for respiratory point-of-care test
1 July 2026 - Molecular diagnostics company Co-Diagnostics Inc (Nasdaq: CODX) disclosed on Monday that it has completed clinical and analytical performance studies supporting its planned FDA submission for the Co-Dx PCR Flu A/B & RSV upper respir...
Hansa Biopharma closes EUR115m Licensing Deal with SERB Pharmaceuticals for Idefirix
1 July 2026 - Immunomodulatory therapy company Hansa Biopharma AB (Nasdaq Stockholm: HNSA) announced on Wednesday that it has completed a EUR115m licensing transaction with SERB Pharmaceuticals covering Idefirix in transplantation across the EU, UK, ...
SciBase submits FDA filing to expand Nevisense use to non‑melanoma skin cancers
1 July 2026 - Swedish medical technology company SciBase Holding AB (STO: SCIB), a developer of AI-based diagnostic solutions for skin disorders, announced on Wednesday that it has submitted a 510(k) premarket notification to the US Food and Drug Adm...